A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation
Authors:
Open Access
- 7 June 2005
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 112 (8) , 1102-1108
Abstract
Objective To assess women's acceptability, the efficacy and side effects of sublingual versus vaginal administration of misoprostol in combination with mifepristone for medical abortion up to 13 weeks of gestation.Design Randomised controlled trial.Setting Aberdeen Royal Infirmary.Population Women undergoing medical abortion under the terms of the 1967 Abortion Act.Methods Mifepristone (200 mg) was given orally followed 36–48 hours later by misoprostol administration (sublingual: 600 μg; vaginal: 800 μg). A second dose of misoprostol 400 μg was given 3 hours later (sublingually or vaginally). Women between 9 and 13 weeks of gestation received a further (third) dose of misoprostol 400 μg (sublingually or vaginally), 3 hours later if abortion had not occurred.Main outcome measures Women's acceptability, efficacy of the regimen and side effects experienced.Results A total of 340 women were recruited (171 sublingual and 169 vaginal). A total of 70% of women in the sublingual group expressed satisfaction with the route of misoprostol administration; 18% answered ‘Don't know’ while 12% were dissatisfied, compared with 68%, 28% and 4%, respectively, in the vaginal group (P= 0.02). There was no significant difference in the need for surgical evacuation for women in the sublingual (3/158, 1.9%) and vaginal groups (4/156, 2.6%) (P= 0.70). Women receiving misoprostol sublingually were more likely to experience diarrhoea (P < 0.01), shivering (P < 0.01) and unpleasant mouth taste (P < 0.01).Conclusions Sublingual administration of misoprostol is an effective alternative to vaginal administration for medical abortion up to 13 weeks of gestation. The prevalence of prostaglandin‐related side effects, however, was higher with this route of administration.Keywords
This publication has 19 references indexed in Scilit:
- Endometrial thickness after misoprostol use for early pregnancy failureInternational Journal of Gynecology & Obstetrics, 2004
- Routine Follow-up Visits After First-Trimester Induced AbortionObstetrics & Gynecology, 2004
- A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestationContraception, 2003
- Factors affecting the outcome of early medical abortion: a review of 4132 consecutive casesBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Expectant management of incomplete, spontaneous first‐trimester miscarriage: outcome according to initial ultrasound criteria and value of follow‐up visitsUltrasound in Obstetrics & Gynecology, 2002
- Medical abortion in the first trimesterBest Practice & Research Clinical Obstetrics & Gynaecology, 2002
- Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancyObstetrics & Gynecology, 1997
- Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal MisoprostolNew England Journal of Medicine, 1995
- Pain of first-trimester abortion: a study of psychosocial and medical predictorsPain, 1989
- Sonar Measurement of Fetal Crown-Rump Length as Means of Assessing Maturity in First Trimester of PregnancyBMJ, 1973